Judges Scientific (LSE:JDG), the acquirer and operator of scientific instrument businesses, is being closely watched after interim results published on 23 September 2026 showed a sharp fall in first-half profit, even as the board maintained its full-year guidance. Chairman David Cicurel described the period as a very poor first half performance, while insisting that the group's strategy remained intact and its fundamentals solid. The company also announced that chief financial officer Brad Ormsby will step down, and director dealing notices have continued, most recently on 6 October.
What the Company Does
Judges Scientific buys and develops small and medium-sized businesses that design and manufacture scientific instruments, used in fields such as materials science, geoscience, vacuum technology and research laboratories. According to its July trading update, the group has 25 businesses acquired since 2005, and its companies have received five Queen's Awards for innovation and export. Its model relies on steady cash generation from these niche operations to fund further acquisitions.
Latest Developments
For the six months to 30 June 2026, Revenue fell 21% to £55.7m from £70.2m. Adjusted pre-tax profit dropped 75% to £3.2m, and adjusted Basic Earnings Per Share fell to 39.0p from about 141p. On a statutory basis the group recorded a pre-tax loss of £1.7m.
In its July trading update the company attributed the weakness to the absence of a Geotek coring expedition, two quarters of sales and orders affected by US federal funding uncertainty, continued postponement of offshore wind projects and delays in Chinese R&D tax exemption processes. Eight businesses grew, helped by a recovery in battery development and strength in semiconductors, and Rest of World revenue rose 9% excluding the coring expedition. Order intake fell 12% compared with the first half of 2025, but by the time of the interim results was only 1% behind, and the order book stood at 17.3 weeks. The company also said the next Geotek coring expedition is not now expected before 2028.
Financial and Dividend Picture
Despite the weak half, the board raised the Interim Dividend by 10% to 36.0p, covered 1.1 times by adjusted earnings. Adjusted net Debt rose to £45.3m from £42.6m at the end of 2025, and gearing increased to 2.1 times from 1.5 times. Banking facilities were extended by two years to July 2030. No acquisitions were completed in the period, although the group cited a healthy pipeline of opportunities.
The board said full-year 2026 guidance remains in line with market expectations for adjusted earnings per share of 200.5p, implying a much firmer second half supported by Patent Box relief, a lower cost base and improvements at underperforming businesses. Market expectations for 2027 stand at 224.9p and exclude any coring revenue.
Sector and index Context
Judges Scientific is a long-standing industrial technology constituent of the FTSE AIM All Share Index. Demand for scientific instruments is closely linked to university and government research budgets, so the uncertainty around US federal funding has affected several suppliers in the sector.
Key Risks
The heavy second-half weighting leaves little room for further order delays. Exposure to research funding in the US and China, offshore wind project timing and the lumpy nature of Geotek's coring work create volatility. Higher gearing could limit Acquisition capacity, and the change of finance director adds transition risk.
What to Watch Next
Investors will look for evidence that third-quarter orders have converted into shipments, a January trading statement confirming whether full-year earnings met market expectations, progress on the search for a new chief financial officer, and any resumption of acquisitions.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...